Trials / Conditions / B-cell Non-Hodgkin Lymphoma (B-NHL)
B-cell Non-Hodgkin Lymphoma (B-NHL)
6 registered clinical trials studyying B-cell Non-Hodgkin Lymphoma (B-NHL) — 4 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | A Trial to Learn How Effective and Safe Odronextamab is Compared to Standard of Care for Adult Participants Wi NCT06230224 | Regeneron Pharmaceuticals | Phase 3 |
| Recruiting | An Early Clinical Study Evaluating the Safety and Efficacy of AcNK-Sup003 Cell Injection in the Treatment of R NCT06693973 | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | EARLY_Phase 1 |
| Recruiting | Study Evaluating UCART20x22 in B-Cell Non-Hodgkin Lymphoma NCT05607420 | Cellectis S.A. | Phase 1 / Phase 2 |
| Active Not Recruiting | Study of PIT565 in Relapsed and/or Refractory B-cell Malignancies NCT05397496 | Novartis Pharmaceuticals | Phase 1 |
| Recruiting | Preliminary Safety and Tolerability of CD19x22 CAR T Cells in Adolescent and Adult R/R B-NHL Patients NCT05098613 | University of Colorado, Denver | Phase 1 |
| Active Not Recruiting | A Study to Assess the Anti-Tumor Activity and Safety of Odronextamab in Adult Patients With B-cell Non-Hodgkin NCT03888105 | Regeneron Pharmaceuticals | Phase 2 |